Accelerate your AAV process development with a new-wave analytical tool

Adeno-associated viruses (AAVs) are widely used vectors for gene therapies, mainly due to their favorable safety profile and high transduction efficiency to various target tissues. With increasing demand for faster process development of advanced therapies using AAVs, rapid at-line analytical chromatographic solutions are becoming indispensable.

PATfix™ analytical system with multiple detectors seamlessly delivers coherent process information, considerably speeding up process development and enabling a fast-paced delivery of the product to the market.

Analytical methods embedded in the PATfix™ system enable at-line monitoring of common product- and process-related impurities and provide a critical platform for the rapid development and characterization of AAV-based gene therapy vectors.

• Analytical platform to support process development and product QC
• Analytical method for E/F separation
• Monitoring impurities and final product analysis
• Analytical platform with multiple detector setup

Andreja Gramc Livk

Head of Process Analytics Development Sartorius BIA Separations

Andreja is a Head of Process Analytics Development department at Sartorius BIA Separations. She leads process analytics development team that focuses on the further advancement of a PATfixTM HPLC solutions, involving the development of innovative methods for the analysis of biological molecules, including mRNA, pDNA and viruses. Over the course of career with biotech companies, she gained a wide range experience in protein chemistry, including characterisation of biosimilars and biologics. She holds a Master Science in Biochemistry from the University of Ljubljana, Slovenia.

Watch now

SPEAKERS

Andreja Gramc Livk

Head of Process Analytics Development Sartorius BIA Separations

You might also like

Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME

Emily Neil, Ariadna Pascual

27 June

in 69

Days

Register

Pure and simple: understanding LNP analytics for better mRNA-based drugs

Adam Crowe

29 May

in 40

Days

Register

Empowering patient care: in-process and quality control solutions for cellular therapies

Christin Tischner, Simon Lennartz

23 May

in 34

Days

Register

T cells from beginning to end: optimizing leukopak and drug product cryopreservation

Meredith Safford, ShaNelle Yelity

22 May

in 33

Days

Register

Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Emily Jackson-Holmes

21 May

in 32

Days

Register